The North West Fund hits the £150m mark

The North West Fund has announced that it has now exceeded the £150m mark having invested in over 440 of the region's businesses since 2010.

Since the Fund was established, it has had a significant impact on the North West economy, boosting GVA by £60m. This figure will continue to rise as investments continue to mature and grow.

The figures reflect the sustained success of the Fund, which has impacted businesses across a range of key North West sectors, including technology, life sciences, energy, manufacturing, and digital and creative, to deliver growth objectives and expansion into new markets.

The Fund has also helped other businesses succeed on the public markets after Manchester molecular diagnostics company Premaitha listed on AIM in 2014, along with Evgen, the Liverpool-based clinical drug development company, which was also admitted to AIM last year.

“Our funding and strategic guidance has enabled businesses to expand into new markets, create additional jobs, along with developing new and existing products. I am certain that these success stories will continue to have a positive impact on the North West economy for many years to come.” The North West Fund is backed by the European Regional Development Fund and European Investment Bank.